Literature DB >> 3251351

Synovial processes in rheumatoid arthritis.

H G Fassbender1, S Gay.   

Abstract

The clinical feature of rheumatoid arthritis (RA) is characterized by systemic-immunological, local-inflammatory phenomena. But it is the joint destruction which gives RA its dramatic course. Through the years we evaluated joint tissues of app. 14,500 patients with defined RA and besides the conventional inflammatory processes we could prove a mechanism which is responsible for the joint destruction and which is typical for RA. Following an exudative episode, compact, homogeneous cell masses can occur in the synovial membrane which consist of macronuclear, immature, synoviogenous cells. These masses can encroach on the adjacent structures of articular cartilage and subchondral bone which consequently enzymatically will be degraded and destroyed. Since these rapidly growing cell masses are avascular in their aggressive stage, they soon will collapse. The surviving cells "modulate" to fibroblast which start collagen synthesis and thus form the well-known pannus. In the area of the compact, homogeneous cell masses of synovial origin, there are no lymphocytes and plasma cells nor PMN or macrophages. Macrophages only occur after the breakdown of the cell masses and the beginning of pannus formation, this also is the case with lymphocytes and plasma cells. Thus, the immature synoviogenous cell masses are in contrast to the initial synovitis not of inflammatory character. Their cytological and aggressive behavior rather shows oncological analogies. This also corresponds to our proof of the expression of myc and ras to a high degree in the aggressive cell masses in RA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3251351     DOI: 10.3109/03009748809102945

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN: 0301-3847


  8 in total

Review 1.  A fibrin based model for rheumatoid synovitis.

Authors:  O Sánchez-Pernaute; R Largo; E Calvo; M A Alvarez-Soria; J Egido; G Herrero-Beaumont
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

Review 2.  [Value of histological work-up for synovial diseases].

Authors:  I Berger; L Morawietz; M Jakobs; V Krenn
Journal:  Orthopade       Date:  2009-06       Impact factor: 1.087

3.  Expression of tenascin-C in aseptic loosening of total hip replacement.

Authors:  Y T Konttinen; T F Li; O Michelsson; J W Xu; T Sorsa; S Santavirta; S Imai; I Virtanen
Journal:  Ann Rheum Dis       Date:  1998-10       Impact factor: 19.103

4.  Starving the synovium: angiogenesis and inflammation in rheumatoid arthritis.

Authors:  G S Firestein
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

5.  15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats.

Authors:  Y Kawahito; M Kondo; Y Tsubouchi; A Hashiramoto; D Bishop-Bailey; K Inoue; M Kohno; R Yamada; T Hla; H Sano
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

6.  Trypsin-2 degrades human type II collagen and is expressed and activated in mesenchymally transformed rheumatoid arthritis synovitis tissue.

Authors:  Mathias Stenman; Mari Ainola; Leena Valmu; Anders Bjartell; Guofeng Ma; Ulf-Håkan Stenman; Timo Sorsa; Reijo Luukkainen; Yrjö T Konttinen
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

7.  C-Reactive Protein Promotes the Activation of Fibroblast-Like Synoviocytes From Patients With Rheumatoid Arthritis.

Authors:  Zhengyu Fang; Jiyang Lv; Jing Wang; Qingxia Qin; Juan He; Meiying Wang; Gengmin Zhou; Guoyu Liu; Fubo Zhong; Yadan Zheng; Hui-Yao Lan; Qingwen Wang
Journal:  Front Immunol       Date:  2020-05-20       Impact factor: 7.561

8.  Treatment of collagen-induced arthritis rat model by using Notch signalling inhibitor.

Authors:  Jianhai Chen; Jian Li; Jinqing Chen; Wenxiang Cheng; Jietao Lin; Liqing Ke; Gang Liu; Xueling Bai; Peng Zhang
Journal:  J Orthop Translat       Date:  2021-03-17       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.